Here, we used advanced edited Magnetic Resonance Spectroscopy (MRS) to measure levels of these low-concentration metabolites in four brain regions of a pediatric cohort
and vision changes
64% of large firms say GLP-1 drug coverage moderately or significantly impacted their prescription drug spending Similar to the findings on use, 43% of firms with 1,000 to 4,999 workers, and 66% of firms with 5,000 or more workers, say that covering GLP-1 agonists for weight loss had a significant impact on the health plans prescription drug spending
In one study, adults who continued to take semaglutide at a maintenance dose did not gain weight, while those who switched to a placebo did
Phentermine has been studied for decades, while semaglutide's weight-loss data (from STEP trials and post-market studies) reflects more recent evidence
Programs are personalized to fit individual needs